Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MOVIVA® Hybrid Ablation Probe

K-Number: K253915 · 2025-12-18

Decision Date2025-12-18
Product CodeGEI
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

MOVIVA® Hybrid Ablation Probe is a medical device manufactured by Erbe Elektromedizin GmbH. It received FDA 510(k) clearance on 2025-12-18 under approval number K253915. The device is classified under product code GEI. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MOVIVA® Hybrid Ablation Probe?

MOVIVA® Hybrid Ablation Probe is a medical device that received FDA 510(k) clearance on 2025-12-18. It is manufactured by Erbe Elektromedizin GmbH. The 510(k) number is K253915.

When was MOVIVA® Hybrid Ablation Probe approved by the FDA?

MOVIVA® Hybrid Ablation Probe received FDA 510(k) clearance on 2025-12-18, under approval number K253915.

What company makes MOVIVA® Hybrid Ablation Probe?

MOVIVA® Hybrid Ablation Probe is manufactured by Erbe Elektromedizin GmbH.

What is the FDA product code for MOVIVA® Hybrid Ablation Probe?

The FDA product code for MOVIVA® Hybrid Ablation Probe is GEI.

Related Clinical Trials

Other Devices by Erbe Elektromedizin GmbH

View all 14 devices →

Related Devices (Code: GEI)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.